In:
Zeitschrift für Naturforschung C, Walter de Gruyter GmbH, Vol. 78, No. 1-2 ( 2023-01-27), p. 27-48
Abstract:
Sakuranetin (SKN), a naturally derived 7- O -methylated flavonoid, was first identified in the bark of the cherry tree ( Prunu s spp.) as an aglycone of sakuranin and then purified from the bark of Prunus puddum . It was later reported in many other plants including Artemisia campestris , Boesenbergia pandurata , Baccharis spp., Betula spp., Juglans spp., and Rhus spp. In plants, it functions as a phytoalexin synthesized from its precursor naringenin and is the only known phenolic phytoalexin in rice, which is released in response to different abiotic and biotic stresses such as UV-irradiation, jasmonic acid, cupric chloride, L-methionine, and the phytotoxin coronatine. Till date, SKN has been widely reported for its diverse pharmacological benefits including antioxidant, anti-inflammatory, antimycobacterial, antiviral, antifungal, antileishmanial, antitrypanosomal, glucose uptake stimulation, neuroprotective, antimelanogenic, and antitumor properties. Its pharmacokinetics and toxicological properties have been poorly understood, thus warranting further evaluation together with exploring other pharmacological properties such as antidiabetic, neuroprotective, and antinociceptive effects. Besides, in vivo studies or clinical investigations can be done for proving its effects as antioxidant and anti-inflammatory, antimelanogenic, and antitumor agent. This review summarizes all the reported investigations with SKN for its health-beneficial roles and can be used as a guideline for future studies.
Type of Medium:
Online Resource
ISSN:
0939-5075
,
1865-7125
DOI:
10.1515/znc-2022-0024
Language:
English
Publisher:
Walter de Gruyter GmbH
Publication Date:
2023
detail.hit.zdb_id:
2078107-6
SSG:
12
Bookmarklink
